Role of colchicine treatment in tumor necrosis factor receptor associated periodic syndrome (TRAPS): real-life data from the AIDA Network

Key Findings

• ●Complete response to colchicine in only 12.5% of TRAPS patients
• ●Partial response in 58.3%, no response in 29.2%
• ●May be considered for milder phenotypes with low amyloidosis risk

Referenced in (1 disease)